Home
Drugs
Cisplatin
Clinical Trials

Clinical Trials Related to Cisplatin

Related studies linked through entity extraction aliases.

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

Status: RECRUITING
Phase: PHASE1

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Status: TERMINATED
Phase: PHASE2

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Status: COMPLETED
Phase: NA

Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer

Status: COMPLETED
Phase: PHASE2

Study Evaluating Efficacy and Safety of Capmatinib in Combination With Osimertinib in Adult Subjects With Non-small Cell Lung Cancers as Second Line Therapy

Status: TERMINATED
Phase: PHASE3

Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)

Status: RECRUITING
Phase: PHASE3

A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer

Status: WITHDRAWN
Phase: PHASE3

Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma

Status: TERMINATED
Phase: PHASE2

A Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor

Status: UNKNOWN
Phase: PHASE1

Pamiparib and Low Dose Temozolomide In Patients With Platinum Sensitive Biliary Tract Cancer

Status: WITHDRAWN
Phase: PHASE2

Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLC

Status: TERMINATED
Phase: PHASE3

Study of Durvalumab in Combination With Platinum and Etoposide for the First Line Treatment of Patients With Extensive-stage Small Cell Lung Cancer

Status: COMPLETED
Phase: PHASE3

Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC

Status: COMPLETED
Phase: PHASE3

Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Status: ENROLLING_BY_INVITATION
Phase: PHASE3

A Study of LP002 for the Treatment of Patients With Malignant Digestive System Neoplasms

Status: UNKNOWN
Phase: PHASE1

Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

Status: TERMINATED
Phase: PHASE1

Study of AZD2811 + Durvalumab in ES-SCLC

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma

Status: COMPLETED
Phase: PHASE2

A Phase 1/2 Study of SC-43 in Combination With Cisplatin

Status: UNKNOWN
Phase: PHASE1/PHASE2